Greek public health research institute providing virus collections and biocontainment expertise within European infectious disease research infrastructure networks.
The Hellenic Pasteur Institute is a public health research centre in Athens specialising in microbiology, virology, and infectious disease. In H2020, they participated in two European research infrastructure networks: one focused on establishing governance and operational frameworks for facilities working with highly pathogenic agents, and one dedicated to virus archiving and the provision of biological reference materials. Their concrete value to these consortia is maintaining curated biological collections and supplying gold-standard virus strains and derived products to other researchers across Europe. They function as a national node that connects Greece to pan-European biocontainment and virus-archiving networks.
ERINHA2 (2016-2017) placed them within the European network for BSL-3/4 research, contributing to operational procedures, legal frameworks, and the research agenda for extreme biocontainment facilities.
EVA-GLOBAL (2020-2024) engaged them in maintaining virus collections and supplying gold-standard products to support scientific response efforts across Europe.
ERINHA2 keywords — legal framework, operational procedure, financial commitment, advocacy — indicate institutional involvement in shaping the governance and sustainability of a shared European research infrastructure.
EVA-GLOBAL keywords include 'support to response' and 'derived products', pointing to a role in supplying biological reagents for diagnostic and outbreak-response purposes.
In their first H2020 project (2016-2017), the institute was engaged in the institutional layer of research infrastructure — legal frameworks, funding models, advocacy, and operational procedures for highly pathogenic agent facilities. This was governance work: building the scaffolding that makes dangerous-pathogen research possible at European scale. By 2020-2024, the focus had shifted to operational delivery — maintaining actual virus collections, producing derived biological products, and supporting scientific response efforts. The trajectory moves from building infrastructure rules to running infrastructure in practice.
They are moving from policy and framework contributions toward operational roles as a biological materials provider, suggesting future value as a specialist node in health-emergency preparedness and diagnostics supply networks.
The Hellenic Pasteur Institute consistently joins as a participant — they have never coordinated an H2020 project. Despite only two projects, they accumulated 42 unique consortium partners across 21 countries, which reflects the large, pan-European nature of research infrastructure consortia rather than a broad personal network. They are a specialist contributor: brought in for a specific national collection or biosafety capability, not for coordination or management.
With 42 partners across 21 countries from just two projects, their network is wide but entirely driven by large infrastructure consortia. There is no evidence of repeat partnerships or a regional cluster — their connections are distributed across the EU and beyond through the EVA and ERINHA networks.
The Hellenic Pasteur Institute is one of the few institutions in Greece with credible standing in maximum-biocontainment and virus-archiving research at European level — membership in ERINHA and EVA-GLOBAL is selective and requires demonstrated biosafety capacity and curated biological collections. For consortium builders working on infectious disease, diagnostics, or biodefense topics, they offer a southern European node with institutional pedigree and access to physical biological resources that most universities cannot provide. Their Pasteur network affiliation adds an international dimension beyond EU borders.
